Capital Research Global Investors Conmed Corp Transaction History
Capital Research Global Investors
- $440 Billion
- Q1 2025
A detailed history of Capital Research Global Investors transactions in Conmed Corp stock. As of the latest transaction made, Capital Research Global Investors holds 1,673,404 shares of CNMD stock, worth $88.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,673,404
Previous 1,577,172
6.1%
Holding current value
$88.5 Million
Previous $108 Million
6.38%
% of portfolio
0.02%
Previous 0.02%
Shares
30 transactions
Others Institutions Holding CNMD
# of Institutions
305Shares Held
36MCall Options Held
162KPut Options Held
5.5K-
Black Rock Inc. New York, NY4.99MShares$264 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$185 Million0.0% of portfolio
-
Earnest Partners LLC Atlanta, GA2.8MShares$148 Million0.84% of portfolio
-
Bank Of America Corp Charlotte, NC1.39MShares$73.8 Million0.01% of portfolio
-
State Street Corp Boston, MA1.3MShares$68.9 Million0.0% of portfolio
About CONMED Corp
- Ticker CNMD
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 30,482,400
- Market Cap $1.61B
- Description
- CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...